NFKB1 and liver cancer: Our previous study revealed that TGR5 can inhibit IκBα phosphorylation and then the nuclear translocation of p65 through enhancing β-arrestin2 interaction with IκBα, resulting in antagonizing the NF-κB signaling pathway in liver cancer cells [7].